logo
  •   Home
  • Applications
    • Indications
  • Business
  • EpiSwitch®
  • Products
    • EpiSwitch® Checkpoint Inhibitor Response Test
    • EpiSwitch® COVID-19 Severity Test
    • EpiSwitch® Explorer Array Kit
    • EPISWITCH® ANALYTICAL PORTAL
    • EpiSwitch® Service
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers
    • Contact Us

oxfordbiodynamics

Final results for year ended 30 September 2021

Press Release


by oxfordbiodynamics

OBD updates on EpiSwitch CST and CiRT tests

Press Release


by oxfordbiodynamics

Circular to Shareholders 26 October 2021

Press Release


by oxfordbiodynamics

OBD raises £3.62 million

Press Release


by oxfordbiodynamics

Change of Registered Office

Press Release


by oxfordbiodynamics

Oxford BioDynamics awarded US FNIH Grant to apply EpiSwitch® Immune Health test for improved prediction of patient response to Immune Checkpoint Inhibitor (ICI) cancer therapies

Press Release


by oxfordbiodynamics

Oxford BioDynamics signs lease for new lab and office space at Oxford Business Park, supporting expanded strategy

Press Release


by oxfordbiodynamics

Oxford BioDynamics signs supply and resale agreement with Agilent® Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use

Press Release


by oxfordbiodynamics

US launch of EpiSwitch® COVID-19 Severity Test

Press Release


by oxfordbiodynamics

EpiSwitch® COVID-19 Severity Test biomarker results published

Press release


by oxfordbiodynamics

  • 1
  • 2
  • 3
  • …
  • 11

Terms of Use / Site Map / Privacy Policy / Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571
© 2002-2021 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences